Trametinib Normalizes Angiopoietin-2 Levels and Successfully Treats Kaposiform Lymphangiomatosis
C. Griffin McDaniel(Cincinnati Children's Hospital Medical Center), Timothy D. Le Cras(Cincinnati Children's Hospital Medical Center), Svatava Merkle(Cincinnati Children's Hospital Medical Center), Rebecca Courtemanche(BC Children's Hospital), Tram Nguyen(BC Children's Hospital), Sophia Lacuna(BC Children's Hospital)
Cited by 4
Related Papers
Inhibition of PI3K by PX-866 Prevents Transforming Growth Factor-α–Induced Pulmonary Fibrosis
|American Journal Of Pathology|2009|62
Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
|Angiogenesis|2020|55
Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO
|Molecular Therapy — Nucleic Acids|2021|16
How we use angiopoietin‐2 in the diagnosis and management of vascular anomalies
|Pediatric Blood & Cancer|2024|14
NRAS <sup>Q61R</sup> mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse model
|Pediatric Blood & Cancer|2024|13